Lazard Capital Downgrades Amgen (AMGN) to Sell
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $442.36 +4.02%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Lazard Capital downgraded Amgen (NASDAQ: AMGN) from Neutral to Sell with a price target of $58.00.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
- Canaccord Downgrades Pro Medicus Ltd. (PME:AU) (PMCUF) to Hold
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
